HCQS

This brand name is authorized in Nigeria.

Active ingredients

The drug HCQS contains one active pharmaceutical ingredient (API):

1	Hydroxychloroquine UNII 8Q2869CNVH - HYDROXYCHLOROQUINE SULFATE
	Hydroxychloroquine is a antimalarial agent with have several pharmacological actions which may be involved in their therapeutic effect in the treatment of rheumatic disease, but its role is not known.
	Read more about Hydroxychloroquine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-7590	Tablet	HCQS Tablets 200mg TAB 200 mg	HCQS TABLETS 200MG 04-7590 HCQS TABLETS 200MG Hydroxychloroquine Sulfate BP 200 mg, Maize starch BP, Calcium Hdrogen Phosphate Dihydrate BP,Colloidal Anhydrous Slica BP, Purified Water BP,Magnesium Stearate BP, Purified Talc BP, Titanium Dioxide BP, Polysorbate-80 (Tween-80) BP,Maize Starch IHT and Marcrogol (6000) BP. Prescription Only Medicine (POM) IPCA PHARMA NIGERIA LIMITED, , OSOLO WAY AJAO ESTATE, LAGOS ISOLO LAGOS IPCA LABORATORIES LTD., P.O SEJAVTA, DIST. RATLAM, PIN: 457002, (M.P.) INDIA., India 23/02/2023 22/02/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BA02	Hydroxychloroquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BA Aminoquinolines
Discover more medicines within P01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-7590